A randomised controlled trial of the monoaminergic stabiliser (-)-OSU6162 in treatment of myalgic encephalomyelitis/chronic fatigue syndrome.
Acta Neuropsychiatr. 2018 Jun;30(3):148-157. doi: 10.1017/neu.2017.35. Epub 2017 Dec 7.
Acta Neuropsychiatr. 2018.
PMID: 29212562
Clinical Trial.